** Brokerage Piper Sandler says it expects lower EBITDA in Q4 2024 and 2025 for chemical companies due to structural issues in the EU and Asia; says U.S. operations may "carry most of the weight"
** Says it will be hard for the companies to generate significant earnings momentum over the next 12-18 months
** Piper Sandler downgrades Dow Chemical DOW.N and LyondellBasell LYB.N to 'neutral' from 'overweight', and cuts PTs to $53 from $60, and $95 from $112, respectively
** Expects Ecolab ECL.N (maintain "overweight", PT cut to $270 from $305) and Olin OLN.N (maintain "overweight", PT cut to $41 from $51), among others, to be in best position to expand earnings partially on lesser degree of overcapacity in their markets
** Brokerage says it does not expect a rebound in China's chemical demand growth and U.S. pricing and margins will not be enough to drive company earnings
** Says stimulus in China and the EU will have more gradual impact than anticipated and might not address overcapacity
(Reporting by Seher Dareen in Bengaluru)
((Seher.Dareen@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。